Location · EgyptUpdated October 13, 2026

Clinical trial software for studies in Egypt

Egypt regulates trials through its own Clinical Trials Law, the Egyptian Drug Authority and a national ethics council, with a newer data protection law on top. Capture gives Egyptian sponsors, universities and investigators a cloud EDC they can build and test without local IT or a service contract.

  • Self-serve, no local IT
  • Documented transfer basis
  • Free sandbox, pay at go-live

Free sandbox · No credit card · 21 CFR Part 11 aligned

Study settings · Region
EG

Study region

Egypt

Trial authority
Egyptian Drug Authority (EDA)
Governing law
Clinical Trials Law 214 of 2020
Ethics
National ethics council plus site committees
Data protection
Personal Data Protection Law 151 of 2020
Hosting region
EU (Frankfurt) or US (N. Virginia)
AES-256 at rest TLS in transit Chosen at study setup

Key points for studies in Egypt

  • The Egyptian Drug Authority (EDA) is the competent authority for clinical trials of investigational drugs and biologics. Its oversight rests on Clinical Trials Law 214 of 2020 and an executive regulation (reported as No. 927 of 2022), read together with ICH GCP.
  • Ethics review has a national layer. The EDA's guideline refers to a Supreme Council for ethics review of clinical medical research whose final approval is required, and sites have their own committees. The English name varies between sources, so confirm the current wording with the EDA.
  • The EDA guideline describes phase rules that differ by product origin, with phases III and IV for foreign-originated interventions allowed only under listed conditions. Ask the EDA how that applies to your product.
  • Personal data is covered by Law 151 of 2020. Its executive regulations were reported as issued in December 2025, with a compliance deadline commonly cited as 31 October 2026. Check the current text and date before you finalise your data plan.
  • Capture hosts in Frankfurt and N. Virginia, not in Egypt. It has no offline mode, so plan connectivity at each site.

Regulation

Law 214 of 2020 and the EDA: what changes for a sponsor

Before Law 214 of 2020, trial oversight in Egypt was spread across several bodies. The law and its executive regulation gave the EDA a central role, including authorising trials, monitoring safety, inspecting sites and checking that sponsors have arranged participant safety and insurance measures. The EDA has published a guideline for good regulatory oversight of clinical trials, with versions updated as recently as March 2026, so download the current edition rather than relying on a summary.

Practically, expect a dossier to the EDA containing the protocol, investigator brochure, consent materials and participating site details, alongside ethics review. Sponsors outside Egypt commonly work through a local legal representative or a partner institution, and your regulatory lead should confirm what the EDA expects. This page cannot decide that for you. What the software can do is shorten the evidence loop: Capture exports a blank eCRF PDF with a cover page, form index and visit-by-form matrix for the submission package, and keeps a field-level audit trail that can answer an inspector's questions later.

Interventional vs observational research

The EDA's GCP guideline is described as applying to interventional medical research on human subjects. Observational, registry and academic questionnaire studies may follow lighter routes, but they usually still need ethics approval. Ask the committee and the EDA which route applies before you build the schedule.

Blank eCRF · no subject data

Visit by form matrix

FormSCRD1W2W4W8EOS
DemographicsX
Vital signsXXXXXX
LaboratoryXXX
ECGXX

3. Was the ECG performed?

☐ Yes☐ No

If No, complete question 4.

Protocol CAP-001 · v1.0Page 3 of 24

Data protection

Law 151 of 2020 and hosting abroad

Egypt's Personal Data Protection Law 151 of 2020 sets out data subject rights, controller and processor duties and a supervisory authority, the Personal Data Protection Center. Its application was held back until executive regulations arrived. Secondary sources report that these were issued in December 2025 and that regulated entities have until around 31 October 2026 to comply, with attention on licences, cross-border transfers and appointing a data protection officer. Sources disagree on regulation numbers and details, so rely on the official text.

For a trial, the questions are familiar. What is the legal basis for processing health data, can the sponsor work with pseudonymised data, and what is the basis for transferring data outside Egypt? Capture hosts in the EU (Frankfurt) or the USA (N. Virginia). Hosting there is a transfer abroad, so state it in the data sharing agreement and participant information, and ask counsel whether a licence or permission is needed. Within Capture, site coordinators see participant names, researchers see coded IDs, and row-level security enforces the split in the database. Compare the logic with GDPR compliant clinical trial software.

Site coordinator

Jane Peterson

DOB: 04-Mar-1978

Subject 01-004

Sees direct identifiers

Researcher

Subject 01-004

DOB: withheld

Coded ID only

Sees coded ID only

Same record, two roles. Row-level security enforces the split.

Test the study before the EDA decision

Build forms, run a mock visit and sign a test consent in the free sandbox. Go live only when the authority and the ethics bodies have cleared the study.

Build your Egyptian study free

Typical start-up

A start-up sequence for Egypt

A sketch for planning, not a regulatory timeline. Confirm every step with the EDA and your ethics committee.

  1. 1

    Choose the route

    Decide whether the study is interventional, observational or a device or diagnostic study, and ask the EDA and committee what applies.

  2. 2

    Prepare the package

    Protocol, investigator brochure, Arabic and English consent materials, insurance evidence and the blank eCRF PDF exported from Capture.

  3. 3

    Ethics review

    Site committee review and the national ethics council step, as the EDA guideline describes. Track amendments as versions.

  4. 4

    EDA authorisation and import

    Authorisation of the trial and any import of investigational product. Do not enrol before it arrives.

  5. 5

    Activate sites

    Create site accounts, train staff and open enrolment site by site. Participant numbers are assigned per site, for example 001-0042.

Egyptian research

University hospitals, investigator-led studies and regional programmes

Egypt has a large patient population, major university hospitals and a growing base of investigators, which makes it a frequent addition to Middle East and North Africa programmes as well as a home for locally sponsored academic studies. Teams without an enterprise EDC budget can use Capture without a setup fee or a per-site fee; the sandbox is free. See EDC for investigator-initiated trials and research data capture for academic studies.

If Egypt is one country in a wider African programme, the regional picture, including joint review routes, is in clinical trial software for Africa. Teams comparing with another large market in the region can also read the Nigeria guide, which has a different regulator and data law.

Before you start

Egypt study set-up checklist

EDA route confirmed

Interventional, observational or device route, plus phase conditions for your product origin.

Ethics approvals mapped

Site committees and the national ethics council, with amendment and report schedules.

Arabic materials approved

Consent, participant information and questionnaire text; instrument licences held in your study file.

Law 151 plan

Legal basis, pseudonymisation, transfer basis and any licence for data hosted in Frankfurt or N. Virginia.

Connectivity fallback

How source is captured when a site loses connection, and who enters it.

Roles and 2FA

Site coordinator, researcher and admin accounts with authenticator-app two-factor sign-in.

FAQ

Questions teams ask before they switch

Something not covered here? Ask us directly.

Who authorises clinical trials in Egypt?

The Egyptian Drug Authority (EDA) authorises trials of investigational drugs and biologics under Clinical Trials Law 214 of 2020. Ethics review runs alongside and includes a national council step. Confirm the current process with the EDA.

Which data protection law applies in Egypt?

Personal Data Protection Law 151 of 2020, with executive regulations reported as issued in December 2025. Check the official text and the compliance date, which sources cite as around 31 October 2026.

Does Capture host data in Egypt?

No. Capture hosts in the EU (Frankfurt) and the USA (N. Virginia). Treat this as a transfer abroad, document the basis and ask counsel whether any permission is required.

Does Capture work offline?

No. Capture is web based and needs a connection to enter data. Plan how sites capture source records when connectivity fails.

Is Capture approved by the EDA?

No regulator approves or certifies EDC software the way it approves a study. Capture provides controls such as an audit trail and e-signatures; your own validated use and submissions are what the EDA reviews.

Can Capture handle Arabic questionnaires?

Participant text is whatever your approved materials say. If you need to understand how a study will handle Arabic and English side by side, talk to us before you commit.

Can I try it free?

Yes. The free sandbox has every feature with no credit card and no time limit.

Build your Egyptian study yourself

Self-serve EDC, eCRF and eConsent. Free sandbox, no credit card.

Build your Egyptian study free